Fondation A de Rothschild
Paris, 75019, France
NCT Number: NCT04428541
In some symmetrical pediatric ocular pathologies, the treatment is surgical with usually satisfactory postoperative results in visual terms.
However, it is often difficult to choose the right moment to operate. The main difficulty is that the child's vision is unknown since the child is still in a preverbal age.
The investigators have developed a questionnaire with the aim of quantifying the child's vision so that the decision is most justified. The items of this questionnaire were established based on the literature and were submitted to a panel of experts in ophthalmo-pediatrics. The objective of this study is to determine the internal validity and as far as possible (since there is no equivalent tool) the external validity of the questionnaire developed.
Looking for future studies?
Notify Me0 month–36 month
All sexes
Interventional
Not applicable
Paris, 75019, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Common to the three groups:
For patients targeted by the questionnaire:
For negative controls:
For positive controls:
Exclusion criteria
18 items questionnaire
Time frame: Inclusion
Reliability evaluated by Cronbach's alpha coefficient and its 95% confidence interval.
unabbreviated scale title : Assessment of Visual Function in Preverbal Children in Bilateral Ocular Pathology
Minimum value : 0
Maximum value : 18
Higher scores mean better outcome
Fondation Ophtalmologique Adolphe de Rothschild
Network
Acronym: EVEIL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03396042
Blindness, Congenital Abnormalities
Miami, Florida, United States
View Trial DetailsNCT03780257
Abnormalities, Multiple, Blindness
Boston, Massachusetts, United States
View Trial DetailsNCT06451172
Antibacterial Therapy, Antibiotic-resistant Bacteria
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT04123626
Autosomal Dominant Retinitis Pigmentosa, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Aurora, Colorado, United States
View Trial Details